Dr. Slavin is a physician-scientist and biotech executive who brings a deep background in clinical genetics and molecular diagnostics to the Tempus leadership team. As the Chief Medical Officer of Diagnostics, he draws on his industry experience and expertise in clinical genetics, molecular diagnostics, and pediatrics. Before joining Tempus, he held key leadership roles as the Chief Clinical Officer of Molecular Oncology at Quest Diagnostics and Chief Medical Officer at Myriad Genetics. He was an assistant professor in the department of Medical Oncology at City of Hope National Medical Center, where he continues to teach in their hereditary genomics program. A dedicated researcher, he has published over 85 journal articles and has been involved in many national cancer research grants, including those from the NIH.